Abattis Bioceuticals Corp. (ATTBF)

[guay]

No chance they dominate the test market. Further, a lab just sold for $3.5M. The market cap here is $23M. That's a problem.

The thing is not to dominate. It's about being in the market. And Northern Vine is not supposed to be sold right now, right?
You already know in which market we are currently investing and what it is, right?
I know that you are not stupid and therefore, I know your criticism to interpret - that should really be clear to you. What is the purpose of your arguments? Will you enlighten us or save us? Come on… phantom views are unpretentious and boring…